Navigation Links
Watson to Present at the Morgan Stanley 2012 Global Healthcare Conference
Date:8/27/2012

PARSIPPANY, N.J., Aug. 27, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Siggi Olafsson, Watson's President, Global Generics, will provide an overview and update of the Company's business at the Morgan Stanley 2012 Global Healthcare Conference on Monday, September 10, 2012 at 10:00AM Eastern Time at the Grand Hyatt in New York, New York. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com.  The webcast can also be accessed at the following URL:

http://cc.talkpoint.com/morg007/091112a_mc/?entity=20_DD853DW

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. The Company is also developing biosimilar products in Women's Health and Oncology.  Additionally, Watson distributes generic and branded pharmaceuticals through its Anda, Inc. distribution business. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

(Logo:  http://photos.prnewswire.com/prnh/20100121/LA41294LOGO )CONTACTS: Investors:Lisa DeFrancesco (862) 261-7152Media:Charlie Mayr(862) 261-8030


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Applauds GPhA Study Demonstrating $1 Trillion in Prescription Drug Savings from Generic Medicines
2. Watson and Actavis Receive FTC Second Request
3. Watsons Generic ARTHROTEC(R) Receives FDA Approval
4. Watson to Host Second Quarter 2012 Earnings Conference Call and Webcast
5. Endo Announces Resolution of Patent Litigation with Watson Pharmaceuticals Related to Lidoderm®
6. Watson Announces Lidoderm® Patent Challenge Settlement
7. Watson to Present at the Jefferies 2012 Global Healthcare Conference
8. Watson Confirms Testim® Patent Challenge
9. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
10. Watson Confirms Lo Loestrin® Fe Patent Challenge
11. Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... , Aug. 15, 2017 AccuGenomics, Inc., ... , today announced that the company has provided ... University of North Carolina at Chapel Hill and to ... designed to characterize and quantify HIV reservoir and viral ... pharmacological intervention. The HIV Cure Center is a joint ...
(Date:8/11/2017)... DarioHealth Corp. (NASDAQ: DRIO), a leading global ... solutions, today announced that it will release its second ... a conference call at 9:00am ET. The Company will ... and its strategy and outlook for the remainder of ... Raphael , Chief Executive Officer, and Zvi Ben-David ...
(Date:8/8/2017)... 2017   Second-quarter ... (GAAP) loss per share from continuing operations ... increased 16 percent to $110 million ... percent to $161 million ... continuing operations increased 8 percent to $0.93 ...
Breaking Medicine Technology:
(Date:8/21/2017)... ... ... San Diego physician and surgeon Dr. James Veltmeyer, author of the Medical ... the 52nd Congressional District currently held by Representative Scott Peters. , “I have ... age eleven after suffering homelessness and hardship in a distant land, I don’t just ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... The ... Excellence Awards (IDSA IDEA®) 2017 Ceremony and Gala on Aug. 19, 2017 in ... one of the world’s most prestigious and rigorous design competitions. See all the winners ...
(Date:8/20/2017)... ... August 20, 2017 , ... ... Compliance Management System has assisted multiple clients in successfully passing audits such ... Organization Control Level 2 (AICPA SOC Level 2), and State Data Use Agreement ...
(Date:8/20/2017)... ... 20, 2017 , ... Are you an adult with gluten intolerance or Celiac ... be interested in participating in a research study that focuses on family interactions when ... about the relational aspects of adults who have gluten sensitivities who cohabitate with other ...
(Date:8/19/2017)... ... ... Western University of Health Sciences will host a special symposium and exhibition about ... on Wednesday, September 6, 2017. , The symposium will be from noon to 1 ... from 1 to 3 p.m. showcasing virtual reality education technology, high speed 3-D printing ...
Breaking Medicine News(10 mins):